首页 > 最新文献

Movement Disorders Clinical Practice最新文献

英文 中文
Quantifying Social Connectedness in Parkinson's Disease: Reliability and Validity of a Clinical Assessment Toolkit. 量化帕金森病患者的社会联系:临床评估工具包的可靠性和有效性。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-13 DOI: 10.1002/mdc3.14298
David Andrés González, Michelle Hyczy de Siqueira Tosin, Tila Warner-Rosen, Christopher G Goetz

Background: Loneliness and isolation impact health detrimentally but are understudied in Parkinson's disease (PD). Outcome measurement properties for social connection remain unexplored in PD.

Objective: To evaluate the measurement properties of six social connection outcomes in PD.

Methods: We evaluated internal consistency, structural validity, and construct validity for measures of loneliness (brief UCLA Loneliness Scale [ULS3], short and long de Jong Gierveld Loneliness Scale [dJGLS], social isolation [Cohen Social Network Index-SNI total people, SNI high contact networks], and social support brief Perceived Social Support Scale [PSS]).

Results: We administered measures to 178 PD participants (Mage = 67.9; 81.5% at Hoehn & Yahr stage 2). There was strong internal consistency, content validity across outcomes, and a 1-factor structure (PSS, ULS3) and a 2-factor structure (dJGLS) for two measures each.

Conclusions: We provide a toolbox for clinicians and researchers studying social connection in PD.

背景:孤独和隔离对健康有不利影响,但对帕金森病(PD)的研究却不足。在帕金森病中,社会联系的结果测量特性仍未得到探讨:评估帕金森病中六种社会联系结果的测量特性:我们评估了孤独感量表(UCLA 孤独感简易量表 [ULS3]、de Jong Gierveld 孤独感简易量表 [dJGLS]、社会隔离 [Cohen 社交网络指数-SNI 总人数、SNI 高接触网络] 和社会支持简易感知社会支持量表 [PSS])的内部一致性、结构效度和构建效度:我们对 178 名帕金森病参与者(年龄=67.9;81.5% 处于 Hoehn & Yahr 第 2 阶段)进行了测量。两个量表具有很强的内部一致性、跨结果的内容效度、单因素结构(PSS、ULS3)和双因素结构(dJGLS):我们为临床医生和研究人员提供了一个研究帕金森病社会联系的工具箱。
{"title":"Quantifying Social Connectedness in Parkinson's Disease: Reliability and Validity of a Clinical Assessment Toolkit.","authors":"David Andrés González, Michelle Hyczy de Siqueira Tosin, Tila Warner-Rosen, Christopher G Goetz","doi":"10.1002/mdc3.14298","DOIUrl":"https://doi.org/10.1002/mdc3.14298","url":null,"abstract":"<p><strong>Background: </strong>Loneliness and isolation impact health detrimentally but are understudied in Parkinson's disease (PD). Outcome measurement properties for social connection remain unexplored in PD.</p><p><strong>Objective: </strong>To evaluate the measurement properties of six social connection outcomes in PD.</p><p><strong>Methods: </strong>We evaluated internal consistency, structural validity, and construct validity for measures of loneliness (brief UCLA Loneliness Scale [ULS3], short and long de Jong Gierveld Loneliness Scale [dJGLS], social isolation [Cohen Social Network Index-SNI total people, SNI high contact networks], and social support brief Perceived Social Support Scale [PSS]).</p><p><strong>Results: </strong>We administered measures to 178 PD participants (M<sub>age</sub> = 67.9; 81.5% at Hoehn & Yahr stage 2). There was strong internal consistency, content validity across outcomes, and a 1-factor structure (PSS, ULS3) and a 2-factor structure (dJGLS) for two measures each.</p><p><strong>Conclusions: </strong>We provide a toolbox for clinicians and researchers studying social connection in PD.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homozygous DNAJC6 Mutated Juvenile Onset Dystonia-Parkinsonism Is Responsive to Pallidal Deep Brain Stimulation.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-10 DOI: 10.1002/mdc3.14300
James Manfield, Marko Bogdanovic, Nagaraja Sarangmat, Sangeeta Scotton, Alexander L Green, James Fitzgerald
{"title":"Homozygous DNAJC6 Mutated Juvenile Onset Dystonia-Parkinsonism Is Responsive to Pallidal Deep Brain Stimulation.","authors":"James Manfield, Marko Bogdanovic, Nagaraja Sarangmat, Sangeeta Scotton, Alexander L Green, James Fitzgerald","doi":"10.1002/mdc3.14300","DOIUrl":"https://doi.org/10.1002/mdc3.14300","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dystonia Improvement with African Dance.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-10 DOI: 10.1002/mdc3.14297
Anna Letícia de Moraes Alves, Igor Vilela Brum, Marcos Castello Barbosa de Oliveira, Egberto Reis Barbosa, Jacy Bezerra Parmera
{"title":"Dystonia Improvement with African Dance.","authors":"Anna Letícia de Moraes Alves, Igor Vilela Brum, Marcos Castello Barbosa de Oliveira, Egberto Reis Barbosa, Jacy Bezerra Parmera","doi":"10.1002/mdc3.14297","DOIUrl":"https://doi.org/10.1002/mdc3.14297","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142800998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No Evidence of Early Developmental Delay in Juvenile-Onset Huntington's Disease Patients.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-07 DOI: 10.1002/mdc3.14287
Lucy Olson, Sarah Dickens, Jordan L Schultz, Mohit Neema, Peggy C Nopoulos

Background: Previous studies suggest that early developmental delay is a common feature of Juvenile-Onset Huntington's disease (JOHD), with highest incidence in those with very high CAG repeats (> 80). However, all reports of developmental delay in JOHD are exclusively based on retrospective review of medical charts. Comprehensive assessment of birth history metrics may provide better insight into the question of early life development in JOHD.

Objective: To explore the prevalence of prematurity, birth complications, low birth weight and developmental delay in patients with JOHD in comparison to control participants.

Methods: Parents of patients with JOHD and gene-non-expanded (GNE) control participants from Kids-HD (n = 104) and Kids-JOHD (n = 34, 24% with CAG > 80) studies completed a comprehensive birth history questionnaire. Answers focused on prematurity, birth complications, and birth weight, and along with reports of early developmental milestones, were compared between groups.

Results: There were no statistically significant differences in prematurity, birth weights, birth complications, or motor and verbal developmental milestones between JOHD patients and GNE controls (all P values > 0.1). Furthermore, stratifying JOHD patients by CAG expansion (low vs. high) also showed no significant differences (GNE vs. low or GNE vs. high).

Conclusions: These findings support the notion that JOHD does not manifest as developmental delay before motor symptom onset and highlight a new framework to understand the course and nature of the disease.

{"title":"No Evidence of Early Developmental Delay in Juvenile-Onset Huntington's Disease Patients.","authors":"Lucy Olson, Sarah Dickens, Jordan L Schultz, Mohit Neema, Peggy C Nopoulos","doi":"10.1002/mdc3.14287","DOIUrl":"https://doi.org/10.1002/mdc3.14287","url":null,"abstract":"<p><strong>Background: </strong>Previous studies suggest that early developmental delay is a common feature of Juvenile-Onset Huntington's disease (JOHD), with highest incidence in those with very high CAG repeats (> 80). However, all reports of developmental delay in JOHD are exclusively based on retrospective review of medical charts. Comprehensive assessment of birth history metrics may provide better insight into the question of early life development in JOHD.</p><p><strong>Objective: </strong>To explore the prevalence of prematurity, birth complications, low birth weight and developmental delay in patients with JOHD in comparison to control participants.</p><p><strong>Methods: </strong>Parents of patients with JOHD and gene-non-expanded (GNE) control participants from Kids-HD (n = 104) and Kids-JOHD (n = 34, 24% with CAG > 80) studies completed a comprehensive birth history questionnaire. Answers focused on prematurity, birth complications, and birth weight, and along with reports of early developmental milestones, were compared between groups.</p><p><strong>Results: </strong>There were no statistically significant differences in prematurity, birth weights, birth complications, or motor and verbal developmental milestones between JOHD patients and GNE controls (all P values > 0.1). Furthermore, stratifying JOHD patients by CAG expansion (low vs. high) also showed no significant differences (GNE vs. low or GNE vs. high).</p><p><strong>Conclusions: </strong>These findings support the notion that JOHD does not manifest as developmental delay before motor symptom onset and highlight a new framework to understand the course and nature of the disease.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basal Ganglia and Prominent Cortical Contouring Calcification in SLC20A2-Related Primary Familial Brain Calcification.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-07 DOI: 10.1002/mdc3.14299
Elisabeth T Boudriot, Nicolin Hainc, Bettina Balint
{"title":"Basal Ganglia and Prominent Cortical Contouring Calcification in SLC20A2-Related Primary Familial Brain Calcification.","authors":"Elisabeth T Boudriot, Nicolin Hainc, Bettina Balint","doi":"10.1002/mdc3.14299","DOIUrl":"https://doi.org/10.1002/mdc3.14299","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxin for Tics: Practical Guidance for Clinicians from a Registry-Based Naturalistic Study.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-07 DOI: 10.1002/mdc3.14296
Tamara Pringsheim, Davide Martino

Background: Botulinum toxin is a recommended treatment for tics. There is little practical guidance on the use of this treatment.

Objectives: Our aim is to describe our experience using botulinum toxin injections for tics in adults. We provide information on tics treated, muscles injected, and dosages used to give practical guidance.

Methods: We analyzed data from the Calgary Adult Tic Registry on tic severity, the tics and muscles injected, and dosages. We assessed treatment length, reasons for discontinuation, and concurrent medications.

Results: Botulinum toxin was the most used medication for tics, received by 32 of 95 (33.7%) registry participants. Participants receiving botulinum toxin were significantly older and had significantly lower vocal tic severity and total tic severity. The most common motor tics treated were blinking, head turns, and shoulder raising. The mean length of treatment was 40.4 months.

Conclusions: Botulinum toxin is an effective and well-tolerated treatment for adults with tics.

{"title":"Toxin for Tics: Practical Guidance for Clinicians from a Registry-Based Naturalistic Study.","authors":"Tamara Pringsheim, Davide Martino","doi":"10.1002/mdc3.14296","DOIUrl":"https://doi.org/10.1002/mdc3.14296","url":null,"abstract":"<p><strong>Background: </strong>Botulinum toxin is a recommended treatment for tics. There is little practical guidance on the use of this treatment.</p><p><strong>Objectives: </strong>Our aim is to describe our experience using botulinum toxin injections for tics in adults. We provide information on tics treated, muscles injected, and dosages used to give practical guidance.</p><p><strong>Methods: </strong>We analyzed data from the Calgary Adult Tic Registry on tic severity, the tics and muscles injected, and dosages. We assessed treatment length, reasons for discontinuation, and concurrent medications.</p><p><strong>Results: </strong>Botulinum toxin was the most used medication for tics, received by 32 of 95 (33.7%) registry participants. Participants receiving botulinum toxin were significantly older and had significantly lower vocal tic severity and total tic severity. The most common motor tics treated were blinking, head turns, and shoulder raising. The mean length of treatment was 40.4 months.</p><p><strong>Conclusions: </strong>Botulinum toxin is an effective and well-tolerated treatment for adults with tics.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Cycling Wheelchair as a New Mobility Aid for Individuals with Parkinson's Disease.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-05 DOI: 10.1002/mdc3.14292
Yohei Okada, Masaru Narita, Masayuki Okamoto, Michihiro Osumi, Shu Morioka
{"title":"The Cycling Wheelchair as a New Mobility Aid for Individuals with Parkinson's Disease.","authors":"Yohei Okada, Masaru Narita, Masayuki Okamoto, Michihiro Osumi, Shu Morioka","doi":"10.1002/mdc3.14292","DOIUrl":"https://doi.org/10.1002/mdc3.14292","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-04 DOI: 10.1002/mdc3.14294
Pawel Jarski, Turab Gasimov, Cristina Dragaescu, Friederike Sixel-Döring, Kajetan von Eckardstein, Brit Mollenhauer, Claudia Trenkwalder, Dorothee Mielke, Veit Rohde, Vesna Malinova

Background: Leucencephalopathy (LE) is often detected on magnetic resonance imaging in elderly patients. These white matter lesions may interfere with lead trajectories for deep brain stimulation (DBS) in patients with Parkinson's disease (PD) and are associated with complications after DBS surgery.

Objective: This study was conducted to assess the incidence of LE in PD patients and to evaluate correlations with complications after DBS surgery.

Methods: A consecutive cohort of PD patients who underwent DBS surgery in the subthalamic nucleus (STN-DBS) was retrospectively analyzed. The presence and extent of LE were quantified using the Fazekas scale. Postoperative complications were extracted from the medical records. DBS efficacy was calculated using the side-specific motor symptom ratio (Unified Parkinson's Disease Rating Scale, Part III, postoperative stimulation ON/medication off divided by preoperative medication off) at 1-year follow-up.

Results: A total of 135 PD patients were included in the study. LE was detected in 35.6% (48/135) of the patients. In 87.7% (57/65), LE was mild, in 10.7% (7/65) moderate, and in 1.6% (1/65) severe. A higher incidence of mild to moderate LE did not correlate with postoperative hemorrhage or postoperative infection. There was no correlation of LE with stimulation efficacy (r = -0.05, P = 0.69) or with surgical index (r = -0.10, P = 0.35).

Conclusions: Neither was the presence of mild to moderate LE associated with an increased risk for surgical complications, nor did it negatively impact the long-term improvement in motor function after DBS surgery in PD patients. Therefore, mild to moderate LE should not be considered a contraindication for DBS.

{"title":"Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation.","authors":"Pawel Jarski, Turab Gasimov, Cristina Dragaescu, Friederike Sixel-Döring, Kajetan von Eckardstein, Brit Mollenhauer, Claudia Trenkwalder, Dorothee Mielke, Veit Rohde, Vesna Malinova","doi":"10.1002/mdc3.14294","DOIUrl":"https://doi.org/10.1002/mdc3.14294","url":null,"abstract":"<p><strong>Background: </strong>Leucencephalopathy (LE) is often detected on magnetic resonance imaging in elderly patients. These white matter lesions may interfere with lead trajectories for deep brain stimulation (DBS) in patients with Parkinson's disease (PD) and are associated with complications after DBS surgery.</p><p><strong>Objective: </strong>This study was conducted to assess the incidence of LE in PD patients and to evaluate correlations with complications after DBS surgery.</p><p><strong>Methods: </strong>A consecutive cohort of PD patients who underwent DBS surgery in the subthalamic nucleus (STN-DBS) was retrospectively analyzed. The presence and extent of LE were quantified using the Fazekas scale. Postoperative complications were extracted from the medical records. DBS efficacy was calculated using the side-specific motor symptom ratio (Unified Parkinson's Disease Rating Scale, Part III, postoperative stimulation ON/medication off divided by preoperative medication off) at 1-year follow-up.</p><p><strong>Results: </strong>A total of 135 PD patients were included in the study. LE was detected in 35.6% (48/135) of the patients. In 87.7% (57/65), LE was mild, in 10.7% (7/65) moderate, and in 1.6% (1/65) severe. A higher incidence of mild to moderate LE did not correlate with postoperative hemorrhage or postoperative infection. There was no correlation of LE with stimulation efficacy (r = -0.05, P = 0.69) or with surgical index (r = -0.10, P = 0.35).</p><p><strong>Conclusions: </strong>Neither was the presence of mild to moderate LE associated with an increased risk for surgical complications, nor did it negatively impact the long-term improvement in motor function after DBS surgery in PD patients. Therefore, mild to moderate LE should not be considered a contraindication for DBS.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local Field Potential-Based Programming for Deep Brain Stimulation in Pediatric DYT1 Dystonia.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-03 DOI: 10.1002/mdc3.14283
James Kelbert, Ashley Guest, Pritha Bisarad, Travis R Larsh, Poonam Bhatia, Sarah Chinander, Patricia Cornejo, Lauren van der Werf, Francisco A Ponce, John A Thompson, Michael C Kruer
{"title":"Local Field Potential-Based Programming for Deep Brain Stimulation in Pediatric DYT1 Dystonia.","authors":"James Kelbert, Ashley Guest, Pritha Bisarad, Travis R Larsh, Poonam Bhatia, Sarah Chinander, Patricia Cornejo, Lauren van der Werf, Francisco A Ponce, John A Thompson, Michael C Kruer","doi":"10.1002/mdc3.14283","DOIUrl":"https://doi.org/10.1002/mdc3.14283","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurophysiological Features of Tremor during Walking in Parkinson's Disease.
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-03 DOI: 10.1002/mdc3.14293
Matteo Costanzo, Francesco Marchet, Giorgio Leodori, Carolina Cutrona, Maria Ilenia De Bartolo, Giorgio Vivacqua, Antonella Conte, Giovanni Fabbrini, Alfredo Berardelli, Daniele Belvisi

Background: In Parkinson's Disease (PD), upper limb tremor during walking (TW) is observed and clinical observations suggest it may represent a variant of rest tremor. However, its neurophysiological characteristics remain unexplored.

Objectives: This study compared the neurophysiological features of TW with other PD tremors and tested whether TW arises from reduced ipsilateral arm swing.

Methods: Inertial measurement units were used to measure frequency and amplitude of tremors and arm swing during walking in 25 PD patients.

Results: TW shared a similar frequency with rest and re-emergent tremor (RET) but showed significantly greater amplitude. A positive correlation was observed between the amplitude and frequency of TW with those of rest and RET on the same side. TW distribution was unrelated to reduced arm swing during walking, suggesting TW is not due to decreased ipsilateral arm movement.

Conclusions: These findings suggest that walking may act as a provocation maneuver, triggering rest tremor.

{"title":"Neurophysiological Features of Tremor during Walking in Parkinson's Disease.","authors":"Matteo Costanzo, Francesco Marchet, Giorgio Leodori, Carolina Cutrona, Maria Ilenia De Bartolo, Giorgio Vivacqua, Antonella Conte, Giovanni Fabbrini, Alfredo Berardelli, Daniele Belvisi","doi":"10.1002/mdc3.14293","DOIUrl":"https://doi.org/10.1002/mdc3.14293","url":null,"abstract":"<p><strong>Background: </strong>In Parkinson's Disease (PD), upper limb tremor during walking (TW) is observed and clinical observations suggest it may represent a variant of rest tremor. However, its neurophysiological characteristics remain unexplored.</p><p><strong>Objectives: </strong>This study compared the neurophysiological features of TW with other PD tremors and tested whether TW arises from reduced ipsilateral arm swing.</p><p><strong>Methods: </strong>Inertial measurement units were used to measure frequency and amplitude of tremors and arm swing during walking in 25 PD patients.</p><p><strong>Results: </strong>TW shared a similar frequency with rest and re-emergent tremor (RET) but showed significantly greater amplitude. A positive correlation was observed between the amplitude and frequency of TW with those of rest and RET on the same side. TW distribution was unrelated to reduced arm swing during walking, suggesting TW is not due to decreased ipsilateral arm movement.</p><p><strong>Conclusions: </strong>These findings suggest that walking may act as a provocation maneuver, triggering rest tremor.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Movement Disorders Clinical Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1